查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2154536

碘基X光造影劑市場：全球市場預測（2026-2032年）

Iodinated X-Ray Contrast Media Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，碘基 X 光造影劑市場將成長至 148.5 億美元，複合年成長率為 10.28%。

主要市場統計數據
基準年 2025 74.8億美元
預計年份：2026年 81.7億美元
預測年份 2032 148.5億美元
複合年成長率 (%) 10.28%

碘基X光造影劑：概述

碘基X光造影劑是一種診斷試劑，用於增強電腦斷層掃描（CT）、血管造影術、透視和其他X光檢查的影像清晰度。其需求受多種因素影響，包括影像檢查的數量、心血管疾病和腫瘤的臨床路徑、急診診斷、醫院基礎設施、監管要求以及低滲透壓和等滲製劑的供應。市場發展也取決於供應穩定性、產品品質、合理使用以及兼顧診斷價值與腎功能、過敏反應和其他病人安全因素的臨床方案。

診斷影像技術的現代化正在改變造影劑的使用方式。

隨著先進CT、影像導引介入、心臟影像影像和急診醫療流程的廣泛應用，市場格局正在改變。醫院越來越重視劑量最佳化、標準化輸液方案、腎臟風險篩檢、過敏管理和快速出具結果。由於生產製造的複雜性、特殊原料、品管以及產能集中度等因素都會影響供應穩定性，因此，供應韌性已成為一項策略挑戰。包裝、廢棄物管理、用水以及含碘殘留物的妥善處置等永續性問題也日益受到關注。

利用人工智慧 (AI) 改進方案選擇和工作流程管理

人工智慧 (AI) 透過輔助影像重建、方案選擇、患者風險分層、自動品質檢查以及優先處理急診檢查，為造影劑工作流程做出貢獻。 AI 可以幫助臨床醫生根據解剖結構、適應症、腎功能和先前影像學檢查結果調整掃描參數和造影劑用量，同時減少因不當檢查而導致的重複檢查。其優勢取決於代表性的訓練資料、透明的檢驗、與放射科和醫院系統的互通性、人工監督以及防止自動化偏差的安全措施。 AI 並不能取代臨床判斷、知情同意、藥物安全監測或遵守既定安全規程的必要性。

區域優先事項包括交通便利性、安全性和影像基礎設施。

北美地區的特點是CT和介入性影像技術的廣泛應用、高度重視流程標準化以及積極主動的供應連續性計劃。歐洲強調在多元化的醫療保健系統中進行臨床管治、保障病人安全、規範採購流程、兼顧環境保護。亞太地區的特點是影像技術發展迅速，但同時在醫療資源取得、保險報銷和醫院設備水準方面存在顯著差異。拉丁美洲的特點是先進影像技術的分佈不均、公立和私立醫療系統之間的差異以及對可靠供應和培訓的需求。中東地區對專科醫院和診斷基礎設施的投資正在推進，但採購、本地化和人力資源發展仍然是重大挑戰。非洲在設備可用性、維護能力、專家配備以及對比增強成像的可及性方面差異最大，因此，建立健全的分銷系統和開展正確使用培訓至關重要。

不同經濟和安全群體之間的實施情況各不相同。

東南亞國協在擴大診斷能力的同時，也努力平衡醫療費用可負擔性、採購協調以及專家配置不平衡等問題。金磚國家在國內製造業、公共部門准入、法律規範和醫療保健投資方面存在顯著差異。歐盟優先考慮安全標準的統一、跨境供應的韌性以及永續性要求。七國集團（G7）的醫療保健系統通常擁有成熟的影像網路、完善的臨床指南和先進的資料基礎設施，但仍在努力控制成本並應對人口老化問題。海灣合作理事會（GCC）國家正在擴大高優先級的診斷和介入醫療服務，通常優先考慮集中採購和技術現代化。北約成員國的醫療保健系統發展水準參差不齊，業務永續營運計畫和醫療物流對於緊急準備至關重要。

各國情況不盡相同，取決於影像技術能力和醫療保健系統的設計。

澳洲面臨先進的診斷影像服務和地理可近性的雙重挑戰，其重點在於如何合理地利用這些服務。巴西對診斷的需求極高，但公立和私立醫療機構之間存在顯著的區域差異。加拿大的醫療體系強調集中規劃、進入管理和向農村地區提供服務。中國正在擴大其診斷影像能力，同時加強國內醫療資源的韌性和法律規範。法國、德國、義大利和西班牙都擁有成熟的歐式醫療體系，但各自在報銷、採購和醫院管治方面採用不同的模式。在印度，診斷服務正在迅速發展，但都市區之間以及公立和私立醫療機構之間仍然存在顯著差異。日本和韓國擁有完善的診斷影像生態系統，對醫療品質有著很高的期望，並且面臨人口老化所帶來的挑戰。墨西哥正在發展其診斷基礎設施，同時努力解決醫療費用可負擔性和區域差異。俄羅斯的醫療環境受到醫療現代化、優先發展國內生產、採購限制的影響。英國強調標準化的臨床路徑、公共醫療體系的效率以及服務提供能力。在美國，先進的診斷影像技術已廣泛應用，採購分散化，並且非常重視安全性、供應連續性和成本控制。

領導階層優先事項：建立韌性、安全性和基於證據的效率。

產業領導者應拓展合格供應商來源，加強緊急儲備，並對活性成分、成品、包裝和分銷環節維持嚴格的品管系統。他們也應與醫院合作，規範作業流程，評估腎臟風險，改善不利事件報告，並加強員工訓練。在產品開發方面，應優先考慮最佳化患者個別化劑量、與現代注射器的兼容性、便於給藥以及降低環境影響，同時確保診斷性能不受影響。實施人工智慧的機構應建立臨床檢驗、監測、網路安全、資料管治和人工干預等方面的程序。策略規劃也應根據公共和私人醫療機構、三級醫療機構和社區醫療機構以及診斷影像資源有限的地區，細分需求，同時確保符合當地法規和保險報銷要求。

調查方法：基於證據的臨床和系統因素評估

本執行摘要採用結構化的定性評估方法，對碘基X光造影劑進行分析，檢驗其臨床應用、影像基礎設施、安全措施、技術應用、供應鏈狀況、法規、採購和醫療保健系統特徵。摘要整合了區域、群體和國家層面的具體觀點，並參考了公開檢驗的證據，包括國家醫療保健政策文件、監管出版刊物、專家臨床指南、同行評審文獻、醫院影像實踐以及已記錄的基礎設施發展趨勢。這種方法避免了不實的數值估算，也不對市場規模、佔有率或預測做出推論。隨著法規、臨床指南、生產狀況和診斷技術的不斷發展，研究結果應及時更新。

結論：永續進步需要可靠的獲取途徑和負責任的創新。

碘基X光造影劑與診斷影像檢查的品質、覆蓋範圍和效率密切相關。進展的關鍵不在於產品本身的供應，而是各方協作改善供應彈性、病患選擇、方案品質、醫護人員能力、基礎設施以及數據驅動的工作流程管理。由於不同地區和國家的情況差異巨大，領導者需要將全球品質標準與本地適用的取得和籌資策略相結合。負責任的AI應用、強化的安全措施以及對環境績效的考量，能夠在確保臨床課責的同時，為可靠的診斷服務提供支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 碘基X光造影劑市場：依產品類型分類

  • 離子
  • 非離子型
    • 二聚非離子型
    • 單體非離子型

第8章：碘基X光造影劑市場：依滲透壓分類

  • 高滲透壓
  • 低滲透壓
    • 等滲壓力
    • 低至中等滲透壓

第9章 碘基X光造影劑市場：依應用領域分類

  • 血管造影術
    • 腦血管造影術
    • 冠動脈攝影術
    • 周邊血管造影術
  • CT影像
    • 多層螺旋CT
    • 單檢測器CT
  • 泌尿道造影
    • 靜脈尿路造影
    • 逆行性泌尿道造影

第10章 碘基X光造影劑市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷中心
    • 診斷影像中心
    • 放射科檢查室
  • 醫院

第11章 碘基X光造影劑市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章 碘基X光造影劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 碘基X光造影劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Arco Life Sciences Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Berlex Laboratories, Inc.
  • Bracco Imaging SpA
  • Fresenius Kabi AG
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Guerbet Group
  • Imax Pharmaceuticals Pvt. Ltd.
  • Iso-Tex Diagnostics, Inc.
  • JB Pharma Pvt. Ltd.
  • Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • Jodas Expoim Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • Livealth Biopharma Pvt. Ltd.
  • Mallinckrodt Pharmaceuticals
  • Novalek Pharmaceuticals Pvt. Ltd.
  • SN Chemicals Pvt. Ltd.
  • Sagent Pharmaceuticals, Inc.
  • Sanochemia Pharmazeutika AG
  • Taejoon Pharm Co., Ltd.
  • Trivitron Healthcare Pvt. Ltd.
  • Unijules Life Sciences Limited
  • Unimark Remedies Limited
  • Venus Pharma Pvt. Ltd.
  • Vifor Pharma AG
  • Yangtze River Pharmaceutical Group Co., Ltd.（YRPG）
  • Zhejiang Starry Pharmaceutical Co., Ltd.

第16章 主要專家

Product Code: MRR-537DB9F46DF8

The Iodinated X-Ray Contrast Media Market is projected to grow by USD 14.85 billion at a CAGR of 10.28% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 7.48 billion
Estimated Year [2026] USD 8.17 billion
Forecast Year [2032] USD 14.85 billion
CAGR (%) 10.28%

Iodinated X-Ray Contrast Media: Executive Overview

Iodinated X-ray contrast media are diagnostic agents used to improve visualization during computed tomography, angiography, fluoroscopy, and other X-ray-based procedures. Demand is shaped by imaging volumes, cardiovascular and oncology care pathways, emergency diagnostics, hospital infrastructure, regulatory requirements, and the availability of low-osmolar and iso-osmolar formulations. Market development also depends on supply continuity, product quality, appropriate use, and clinical protocols that balance diagnostic value with renal, allergic, and other patient-safety considerations.

Imaging Modernization Is Reshaping Contrast-Media Use

The landscape is changing through wider adoption of advanced CT, image-guided intervention, cardiac imaging, and emergency-care workflows. Hospitals are placing greater emphasis on dose optimization, standardized injection protocols, renal-risk screening, allergy management, and rapid turnaround. Supply resilience has become a strategic concern because manufacturing complexity, specialized raw materials, quality controls, and concentrated production capacity can affect availability. Sustainability considerations are also gaining attention, including packaging, waste handling, water use, and responsible disposal of iodinated residues.

Artificial Intelligence Improves Protocol Selection and Workflow Control

Artificial intelligence is contributing to contrast-media workflows by supporting image reconstruction, protocol selection, patient-risk stratification, automated quality checks, and prioritization of urgent examinations. AI can help clinicians tailor scan parameters and contrast administration to anatomy, indication, renal function, and prior imaging, while reducing repeat examinations caused by suboptimal studies. Its benefits depend on representative training data, transparent validation, interoperability with radiology and hospital systems, human oversight, and safeguards against automation bias. AI does not remove the need for clinical judgment, informed consent, pharmacovigilance, or adherence to established safety procedures.

Regional Priorities Span Access, Safety, and Imaging Infrastructure

North America is characterized by extensive CT and interventional-imaging use, strong attention to protocol standardization, and active supply-continuity planning. Europe emphasizes clinical governance, patient safety, procurement discipline, and environmental considerations across diverse health systems. Asia-Pacific combines rapid imaging-capacity development with substantial variation in access, reimbursement, and hospital sophistication. Latin America is shaped by uneven distribution of advanced imaging, public-private system differences, and the need for dependable supply and training. The Middle East is investing in specialized hospitals and diagnostic infrastructure, while procurement, localization, and workforce development remain important. Africa faces the greatest variation in equipment availability, maintenance capacity, specialist staffing, and access to contrast-supported imaging, making resilient distribution and appropriate-use training central priorities.

Economic and Security Groups Reveal Different Adoption Conditions

ASEAN countries are balancing expanding diagnostic capacity with affordability, procurement coordination, and uneven specialist coverage. BRICS members reflect broad differences in domestic manufacturing, public-sector access, regulatory pathways, and healthcare investment. The European Union places importance on harmonized safety expectations, cross-border supply resilience, and sustainability requirements. G7 systems generally have mature imaging networks, established clinical guidance, and advanced data infrastructure, while still addressing cost control and aging populations. GCC countries are expanding high-acuity diagnostic and interventional services and often prioritize centralized procurement and technology modernization. NATO members span highly developed and more variable health systems, with continuity planning and medical logistics relevant to emergency preparedness.

Country Conditions Differ by Imaging Capacity and Health-System Design

Australia combines advanced imaging services with geographic access challenges and a focus on appropriate use. Brazil has substantial diagnostic demand alongside regional disparities between public and private provision. Canada's system emphasizes centralized planning, access management, and rural service delivery. China is expanding imaging capacity while strengthening domestic supply resilience and regulatory oversight. France, Germany, Italy, and Spain operate mature European health systems with differing reimbursement, procurement, and hospital-governance models. India is experiencing broad diagnostic expansion but retains major urban-rural and public-private gaps. Japan and South Korea have sophisticated imaging ecosystems, strong quality expectations, and aging-population needs. Mexico is developing diagnostic infrastructure while addressing affordability and geographic variation. Russia's environment is influenced by healthcare modernization, domestic production priorities, and procurement constraints. The United Kingdom emphasizes standardized clinical pathways, public-system efficiency, and service capacity. The United States has extensive advanced imaging use, decentralized purchasing, and strong focus on safety, supply continuity, and cost management.

Leadership Priorities: Build Resilience, Safety, and Evidence-Based Efficiency

Industry leaders should diversify qualified supply sources, strengthen contingency inventories, and maintain rigorous quality systems for active ingredients, finished products, packaging, and distribution. They should partner with hospitals to improve protocol standardization, renal-risk assessment, adverse-event reporting, and staff education. Product development should prioritize patient-specific dosing, compatibility with modern injectors, ease of administration, and reduced environmental burden without compromising diagnostic performance. Organizations adopting AI should establish clinical validation, monitoring, cybersecurity, data-governance, and override procedures. Strategic planning should also segment needs by public and private care, tertiary and community settings, and regions with limited imaging access, while aligning engagement with local regulatory and reimbursement requirements.

Methodology: Evidence-Based Assessment of Clinical and System Drivers

This executive summary uses a structured qualitative assessment of iodinated X-ray contrast media, examining clinical applications, imaging infrastructure, safety practices, technology adoption, supply-chain conditions, regulation, procurement, and healthcare-system characteristics. Regional, group, and country perspectives are integrated using publicly verifiable categories of evidence such as national health-policy documents, regulatory publications, professional clinical guidance, peer-reviewed literature, hospital-imaging practices, and documented infrastructure trends. The approach avoids unsupported numerical estimates and does not infer market size, share, or forecasts. Findings should be updated as regulations, clinical guidelines, manufacturing conditions, and diagnostic technologies evolve.

Conclusion: Sustainable Progress Requires Reliable Access and Responsible Innovation

Iodinated X-ray contrast media remain closely tied to the quality, reach, and efficiency of diagnostic imaging. Progress will depend less on product availability alone than on coordinated improvements in supply resilience, patient selection, protocol quality, workforce capability, infrastructure, and data-enabled workflow management. Regional and national conditions vary substantially, so leaders should combine global quality standards with locally appropriate access and procurement strategies. Responsible adoption of AI, stronger safety systems, and attention to environmental performance can support dependable diagnostic care while preserving clinical accountability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Iodinated X-Ray Contrast Media Market, by Product Type

  • 7.1. Introduction
  • 7.2. Ionic
  • 7.3. Non Ionic
    • 7.3.1. Dimeric Non Ionic
    • 7.3.2. Monomeric Non Ionic

8. Iodinated X-Ray Contrast Media Market, by Osmolarity

  • 8.1. Introduction
  • 8.2. High Osmolar
  • 8.3. Low Osmolar
    • 8.3.1. Iso Osmolar
    • 8.3.2. Low Medium Osmolar

9. Iodinated X-Ray Contrast Media Market, by Application

  • 9.1. Introduction
  • 9.2. Angiography
    • 9.2.1. Cerebral Angiography
    • 9.2.2. Coronary Angiography
    • 9.2.3. Peripheral Angiography
  • 9.3. Ct Imaging
    • 9.3.1. Multi Detector Ct
    • 9.3.2. Single Detector Ct
  • 9.4. Urography
    • 9.4.1. Intravenous Urography
    • 9.4.2. Retrograde Urography

10. Iodinated X-Ray Contrast Media Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Clinics
  • 10.4. Diagnostic Centers
    • 10.4.1. Imaging Centers
    • 10.4.2. Radiology Laboratories
  • 10.5. Hospitals

11. Iodinated X-Ray Contrast Media Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Iodinated X-Ray Contrast Media Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Iodinated X-Ray Contrast Media Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Arco Life Sciences Pvt. Ltd.
  • 15.2. Bayer AG
  • 15.3. Beijing Beilu Pharmaceutical Co., Ltd.
  • 15.4. Berlex Laboratories, Inc.
  • 15.5. Bracco Imaging S.p.A.
  • 15.6. Fresenius Kabi AG
  • 15.7. Fujifilm Holdings Corporation
  • 15.8. GE Healthcare
  • 15.9. Guerbet Group
  • 15.10. Imax Pharmaceuticals Pvt. Ltd.
  • 15.11. Iso-Tex Diagnostics, Inc.
  • 15.12. JB Pharma Pvt. Ltd.
  • 15.13. Jiangsu Hengrui Pharmaceuticals Co., Ltd.
  • 15.14. Jodas Expoim Pvt. Ltd.
  • 15.15. Lantheus Medical Imaging, Inc.
  • 15.16. Livealth Biopharma Pvt. Ltd.
  • 15.17. Mallinckrodt Pharmaceuticals
  • 15.18. Novalek Pharmaceuticals Pvt. Ltd.
  • 15.19. S. N. Chemicals Pvt. Ltd.
  • 15.20. Sagent Pharmaceuticals, Inc.
  • 15.21. Sanochemia Pharmazeutika AG
  • 15.22. Taejoon Pharm Co., Ltd.
  • 15.23. Trivitron Healthcare Pvt. Ltd.
  • 15.24. Unijules Life Sciences Limited
  • 15.25. Unimark Remedies Limited
  • 15.26. Venus Pharma Pvt. Ltd.
  • 15.27. Vifor Pharma AG
  • 15.28. Yangtze River Pharmaceutical Group Co., Ltd. (YRPG)
  • 15.29. Zhejiang Starry Pharmaceutical Co., Ltd.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Iodinated X-Ray Contrast Media Market, Years Considered for the Study
  • FIGURE 2. Global Iodinated X-Ray Contrast Media Market, Research Design
  • FIGURE 3. Global Iodinated X-Ray Contrast Media Market, Research Framework
  • FIGURE 4. Global Iodinated X-Ray Contrast Media Market, Data Triangulation
  • FIGURE 5. Global Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2025 vs 2032 (%)
  • FIGURE 9. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2025 vs 2032 (%)
  • FIGURE 11. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 13. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Iodinated X-Ray Contrast Media Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Iodinated X-Ray Contrast Media Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Iodinated X-Ray Contrast Media Market Segmentation & Coverage
  • TABLE 2. Global Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 4. Global Ionic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Ionic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Ionic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Non Ionic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Non Ionic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Non Ionic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Dimeric Non Ionic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Dimeric Non Ionic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Dimeric Non Ionic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Monomeric Non Ionic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Monomeric Non Ionic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Monomeric Non Ionic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 17. Global High Osmolar Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global High Osmolar Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global High Osmolar Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Low Osmolar Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Low Osmolar Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Low Osmolar Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Iso Osmolar Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 24. Global Iso Osmolar Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 25. Global Iso Osmolar Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 26. Global Low Medium Osmolar Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 27. Global Low Medium Osmolar Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 28. Global Low Medium Osmolar Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 29. Global Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 30. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Cerebral Angiography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 34. Global Cerebral Angiography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 35. Global Cerebral Angiography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 36. Global Coronary Angiography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 37. Global Coronary Angiography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 38. Global Coronary Angiography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 39. Global Peripheral Angiography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 40. Global Peripheral Angiography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 41. Global Peripheral Angiography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 42. Global Ct Imaging Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 43. Global Ct Imaging Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 44. Global Ct Imaging Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 45. Global Multi Detector Ct Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 46. Global Multi Detector Ct Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 47. Global Multi Detector Ct Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 48. Global Single Detector Ct Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 49. Global Single Detector Ct Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 50. Global Single Detector Ct Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 51. Global Urography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 52. Global Urography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 53. Global Urography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 54. Global Intravenous Urography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 55. Global Intravenous Urography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 56. Global Intravenous Urography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 57. Global Retrograde Urography Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 58. Global Retrograde Urography Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 59. Global Retrograde Urography Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 60. Global Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 61. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 62. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 63. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 64. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 65. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 66. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 67. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 68. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 69. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 70. Global Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 71. Global Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 72. Global Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 73. Global Radiology Laboratories Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 74. Global Radiology Laboratories Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 75. Global Radiology Laboratories Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 76. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 77. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 78. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 79. Global Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 80. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 81. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 82. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 83. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 84. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 85. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 86. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 87. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 89. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 91. North America Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 92. North America Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 93. North America Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 94. North America Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 95. North America Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 96. North America Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 97. North America Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 98. North America Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 99. North America Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 100. North America Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 101. North America Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 102. Latin America Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Latin America Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 104. Latin America Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 105. Latin America Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 106. Latin America Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 107. Latin America Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 108. Latin America Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 109. Latin America Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 110. Latin America Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 111. Latin America Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 112. Latin America Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 113. Europe Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 114. Europe Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 115. Europe Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 116. Europe Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 117. Europe Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 118. Europe Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 119. Europe Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 120. Europe Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 121. Europe Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 122. Europe Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 123. Europe Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 124. Middle East Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Middle East Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 126. Middle East Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 127. Middle East Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 128. Middle East Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 129. Middle East Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 130. Middle East Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 131. Middle East Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 132. Middle East Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 133. Middle East Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 134. Middle East Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 135. Africa Iodinated X-Ray Contrast Media Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 136. Africa Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 137. Africa Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 138. Africa Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 139. Africa Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 140. Africa Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 141. Africa Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 142. Africa Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 143. Africa Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 144. Africa Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 145. Africa Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 146. Global Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 147. ASEAN Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 148. ASEAN Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 149. ASEAN Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 150. ASEAN Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 151. ASEAN Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 152. ASEAN Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 153. ASEAN Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 156. ASEAN Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 157. ASEAN Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 158. GCC Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 159. GCC Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 160. GCC Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 161. GCC Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 162. GCC Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 163. GCC Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 164. GCC Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 165. GCC Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 166. GCC Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 167. GCC Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 168. GCC Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 169. European Union Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 170. European Union Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 171. European Union Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 172. European Union Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 173. European Union Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 174. European Union Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 175. European Union Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 176. European Union Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 177. European Union Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 178. European Union Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 179. European Union Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 180. BRICS Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 181. BRICS Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 182. BRICS Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 183. BRICS Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 184. BRICS Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 185. BRICS Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 186. BRICS Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 187. BRICS Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 188. BRICS Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 189. BRICS Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 190. BRICS Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 191. G7 Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 192. G7 Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 193. G7 Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 194. G7 Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 195. G7 Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 196. G7 Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 197. G7 Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 198. G7 Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 199. G7 Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 200. G7 Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 201. G7 Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 202. NATO Iodinated X-Ray Contrast Media Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 203. NATO Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 204. NATO Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 205. NATO Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 206. NATO Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 207. NATO Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 208. NATO Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 209. NATO Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 210. NATO Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 211. NATO Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 212. NATO Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 213. Global Iodinated X-Ray Contrast Media Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 214. United States Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 215. United States Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 216. United States Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 217. United States Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 218. United States Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 219. United States Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 220. United States Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 221. United States Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 222. United States Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 223. United States Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 224. United States Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 225. Canada Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 226. Canada Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 227. Canada Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 228. Canada Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 229. Canada Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 230. Canada Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 231. Canada Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 232. Canada Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 233. Canada Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 234. Canada Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 235. Canada Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 236. Mexico Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 237. Mexico Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 238. Mexico Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 239. Mexico Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 240. Mexico Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 241. Mexico Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 242. Mexico Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 243. Mexico Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 244. Mexico Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 245. Mexico Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 246. Mexico Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 247. Brazil Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 248. Brazil Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 249. Brazil Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 250. Brazil Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 251. Brazil Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 252. Brazil Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 253. Brazil Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 254. Brazil Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 255. Brazil Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 256. Brazil Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 257. Brazil Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 260. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 261. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 262. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 263. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 264. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 265. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 266. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 267. United Kingdom Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 268. United Kingdom Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 269. Germany Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 270. Germany Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 271. Germany Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 272. Germany Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 273. Germany Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 274. Germany Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 275. Germany Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 276. Germany Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 277. Germany Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 278. Germany Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 279. Germany Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 280. France Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 281. France Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 282. France Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 283. France Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 284. France Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 285. France Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 286. France Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 287. France Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 288. France Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 289. France Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. France Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 291. Russia Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 292. Russia Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 293. Russia Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 294. Russia Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 295. Russia Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 296. Russia Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 297. Russia Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 298. Russia Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 299. Russia Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 300. Russia Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 301. Russia Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 302. Italy Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 303. Italy Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 304. Italy Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 305. Italy Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 306. Italy Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 307. Italy Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 308. Italy Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 309. Italy Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 310. Italy Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 311. Italy Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 312. Italy Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 313. Spain Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 314. Spain Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 315. Spain Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 316. Spain Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 317. Spain Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 318. Spain Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 319. Spain Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 320. Spain Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 321. Spain Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 322. Spain Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 323. Spain Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 324. China Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 325. China Iodinated X-Ray Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
  • TABLE 326. China Iodinated X-Ray Contrast Media Market Size, by Non Ionic, 2017-2032 (USD Million)
  • TABLE 327. China Iodinated X-Ray Contrast Media Market Size, by Osmolarity, 2017-2032 (USD Million)
  • TABLE 328. China Iodinated X-Ray Contrast Media Market Size, by Low Osmolar, 2017-2032 (USD Million)
  • TABLE 329. China Iodinated X-Ray Contrast Media Market Size, by Application, 2017-2032 (USD Million)
  • TABLE 330. China Iodinated X-Ray Contrast Media Market Size, by Angiography, 2017-2032 (USD Million)
  • TABLE 331. China Iodinated X-Ray Contrast Media Market Size, by Ct Imaging, 2017-2032 (USD Million)
  • TABLE 332. China Iodinated X-Ray Contrast Media Market Size, by Urography, 2017-2032 (USD Million)
  • TABLE 333. China Iodinated X-Ray Contrast Media Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 334. China Iodinated X-Ray Contrast Media Market Size, by Diagnostic Centers, 2017-2032 (USD Million)
  • TABLE 335. India Iodinated X-Ray Contrast Media Market Size, 2017-2032 (USD Million)
  • TABLE 336. India Iodinated X-Ray Contrast Media Market Size, by Product